Cecilia Schott, Head Precision Medicine Strategy Oncology Business Unit at Novartis
Cecilia Schott is Head Precision Medicine Strategy Oncology Business Unit at Novartis. Prior to her current role Cecilia held positions VP, Precision Medicine for AstraZeneca Global Product & Portfolio Strategy, Global Marketing and US Medical Affairs. Cecilia background includes roles in the biotech and device industries. Before joining AstraZeneca she was part of Biogena Drug Safety and Medical Information function, and at Boston Scientific she was responsible for establishing the drug eluting stent franchise Medical Publications and Medical Information groups as part of Medical Affairs.
Cecilia holds a BS in Pharmacy from University of Sao Paulo, Brazil; a Doctor of Pharmacy degree from the Massachusetts College of Pharmacy, Boston, and a MBA from Babson College, Boston.